Marilena Gilca Selected Research

Dyslipidemias (Dyslipidemia)

12/2014

A study of antioxidant activity in patients with schizophrenia taking atypical antipsychotics.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marilena Gilca Research Topics

Disease

1	Skin Diseases (Skin Disease) 12/2023
1	Neoplasms (Cancer) 11/2023
1	Inflammation (Inflammations) 11/2022
1	Necrosis 01/2018
1	Dyslipidemias (Dyslipidemia) 12/2014
1	Weight Gain 12/2014
1	Schizophrenia (Dementia Praecox) 12/2014
1	Alzheimer Disease (Alzheimer's Disease) 10/2014
1	Adenoma (Adenomas) 01/2011

Drug/Important Bio-Agent (IBA)

4	PhytochemicalsIBA 12/2023 - 01/2018
2	AntioxidantsIBA 01/2018 - 12/2014
1	FlavonoidsIBA 01/2018
1	NitrilesIBA 01/2018
1	tetramethylpyrazineIBA 01/2018
1	ResveratrolIBA 01/2018
1	AlkaloidsIBA 01/2018
1	AnthraquinonesIBA 01/2018
1	LactonesIBA 01/2018
1	embelinIBA 01/2018
1	Rutin (Rutoside)IBA 01/2018
1	SesquiterpenesIBA 01/2018
1	LignansIBA 01/2018
1	Inhibitor of Apoptosis ProteinsIBA 01/2018
1	InflammasomesIBA 01/2018
1	PolyphenolsIBA 01/2018
1	Risperidone (Risperdal Consta)FDA LinkGeneric 12/2014
1	Aryldialkylphosphatase (Paraoxonase)IBA 12/2014
1	Antipsychotic Agents (Antipsychotics)IBA 12/2014
1	LipidsIBA 12/2014
1	Clozapine (Clozaril)FDA LinkGeneric 12/2014
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 10/2014
1	Urethane (Ethyl Carbamate)IBA 01/2011